The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy also had a surprising property.

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

Korean biosimilar giant Celltrion announced on Wednesday that it will present its vision and strategy for novel drug ...

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...